InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank86
3Y CAGR-14.2%
5Y CAGR+0.5%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-14.2%/yr
Annual compound
5Y CAGR
+0.5%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20250.06-47.2%
20240.10+222.7%
20230.03-62.9%
20220.09+139.1%
20210.04-32.2%
20200.05-
20190.00-
20180.00-
20170.00-
20160.00-